openPR Logo
Press release

Prenatal and New-born Genetic Testing Market Is Anticipated to Grow up to USD 20.9 Billion by 2032

12-21-2023 04:22 PM CET | Health & Medicine

Press release from: Global Insight Services

Prenatal and New-born Genetic Testing Market Is Anticipated

Prenatal testing provides you with information about your baby's health. It detects any problems that could affect the health of fetuses like genetic defects and congenital conditions. Doctors recommend some prenatal tests while only a few women need special screening tests. Newborn testing is done to detect abnormalities that can cause certain health conditions such as inborn genetic defects. The genetic diseases that can be detected in newborns during screening are Down syndrome, homocystinuria, and others. Therefore it is important to diagnose genetic diseases in the early stages of the pregnancy and within 24 hours of newborn birth.

Download Sample PDF Of This Report:
https://www.globalinsightservices.com/request-sample/GIS10516/?utm_id=1018

Market Trends and Drivers
Growing consanguineous relations in African and Asian countries is expected to stimulate the market expansion

Growing rate of traditional consanguineous marriages that fuels the risk of autosomal recessive disorders in the newborn is amongst the key factors boosting the prenatal and new-born genetic testing market progression. Marrying in closely related family members is tradition in several countries in Middle East, West Asia, East Asia and North Africa region with almost half of the marriages being consanguineous. The emigrant from these regions continue the tradition and are contributing to the surging rates of genetic disorders. Consanguineous marriage results in transfer of two recessive defective mechanisms from the parents and the offspring may inherit these genes causing the congenital anomalies. Around 1 billion people reside in the countries that commonly practice marriage among relatives. Amongst them, 1 out of 3 individuals are married to a second cousin or closely related family member. The risk of having genetic defects or chromosomal abnormalities among offspring of such marriages is almost two-fold.

Request Customization:
https://www.globalinsightservices.com/request-customization/GIS10516/?utm_id=1018

Major Players in the Global Prenatal and New-born Genetic Testing Market
The key players in the Prenatal and New-born Genetic Testing Market are Ariosa Diagnostics (Roche), Berry Genomics, BGI, Biorad, Illumina, Laboratory Corporation of America, Natera, Qiagen, Sequenom, Trivitron Healthcare and Verinata Health among others.

COVID-19 Impact:
The outbreak of COVID-19 has disrupted workflows in the healthcare sector around the world. The disease has forced a number of industries to shut their doors temporarily, including several sub-domains of health care. The global prenatal and newborn genetic testing market experienced a decline in 2020 due to the global economic recession led by COVID-19. In addition, the COVID-19 outbreak disrupted the supply chain across various end-user industries like food & beverage, healthcare, and industrial. However, the market is anticipated to witness recovery in 2021, and show stable growth for prenatal and newborn genetic testing market in the coming future. This is attributed to the increase in the adoption novel screening methods in developing countries such as China and India.

Recent Developments:
In August 2022, F. Hoffman-La Roche AG has launched the Digital LightCycler System a next-generation digital PCR system that helps physicians to better understand the nature of genetic diseases.
In August 2022, Natera Inc. filed a pre-submission to the Food and Drug Administration (FDA) for its panorama non-invasive prenatal test (NIPT) as part of the Q-Sub process. The company filed its pre-submission in June 2022 for fetal chromosomal aneuploidies and 22q11.2 deletion syndrome.
In July 2022, Genetic Technologies Limited acquired EasyDNA as the company expanded the availability on its websites of Carrier Testing and Non-Invasive Prenatal Tests (NIPT) in Europe.

Procure Complete Report (PDF with Insights, Charts, Tables, and Figures)
https://www.globalinsightservices.com/checkout/single_user/GIS10516/?utm_id=1018

Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Prenatal and New-born Genetic Testing Market Is Anticipated to Grow up to USD 20.9 Billion by 2032 here

News-ID: 3335526 • Views:

More Releases from Global Insight Services

Glp-1 Agonist Market To Surge From $53 BN To $264.9 BN By 2034 At 17.5% Cagr. Key Players: Hanmi Pharmaceutical, Zydus Cadila, Oramed Pharmaceuticals.
Glp-1 Agonist Market To Surge From $53 BN To $264.9 BN By 2034 At 17.5% Cagr. Ke …
Market Overview GLP-1 Agonist Market is rapidly evolving as the demand for advanced diabetes and obesity treatments continues to rise globally. These drugs, known as glucagon-like peptide-1 receptor agonists, help improve insulin secretion, reduce glucagon levels, and enhance satiety-making them a powerful solution for type 2 diabetes and weight management. With diabetes and obesity reaching unprecedented levels, the GLP-1 Agonist Market stands at the forefront of therapeutic innovation. Growing patient awareness,
Financial Risk Management Software Market To Grow From $24.5 BN To $47.8 BN By 2034 At 6.9% Cagr. Key Players: Activeviam, Sas Risk Management, Fiserv.
Financial Risk Management Software Market To Grow From $24.5 BN To $47.8 BN By 2 …
Market Overview Financial Risk Management Software Market is evolving rapidly as financial institutions and enterprises navigate increasingly complex global uncertainties. With tightening regulations and growing exposure to market volatility, organizations are turning toward advanced digital solutions that help identify, assess, and mitigate financial risks in real time. The Financial Risk Management Software Market integrates AI, machine learning, predictive analytics, and cloud technologies to enhance credit, liquidity, operational, and market risk insights.
Esg Risk Management Market To Rise From $268.8 MN To $1,032.2 MN By 2034 At 14.4% Cagr. Key Players: Sustainalytics, Reprisk, Arabesque.
Esg Risk Management Market To Rise From $268.8 MN To $1,032.2 MN By 2034 At 14.4 …
Market Overview ESG Risk Management Market is gaining significant momentum as businesses increasingly prioritize sustainability and ethical governance in their operations. Valued at $268.8 million in 2024, the market is projected to surge to $1,032.2 million by 2034, growing at a CAGR of 14.4%. The ESG Risk Management Market encompasses technologies and services designed to identify, monitor, and mitigate environmental, social, and governance risks, ensuring businesses operate responsibly while complying with
Enterprise Firewall Market To Grow From $15 BN (2024) To $40.3 BN (2034) At 10.4% Cagr. Key Players: Sonicwall, Watchguard, Palo Alto Networks.
Enterprise Firewall Market To Grow From $15 BN (2024) To $40.3 BN (2034) At 10.4 …
Market Overview Enterprise Firewall Market is witnessing substantial growth as organizations worldwide prioritize safeguarding their digital infrastructure from sophisticated cyber threats. Valued at $15 billion in 2024, the market is projected to reach $40.3 billion by 2034, expanding at a CAGR of 10.4%. The Enterprise Firewall Market encompasses solutions designed to secure enterprise networks by monitoring, filtering, and blocking unauthorized access while ensuring uninterrupted business operations. With the surge in cyberattacks,

All 5 Releases


More Releases for Prenatal

Non-Invasive Prenatal Testing (NIPT) Market Set to Transform Prenatal Care World …
Market Overview The global non-invasive prenatal testing NIPT market reached US$ 6.31 billion in 2023 and increased to US$ 7.35 billion in 2024. It is projected to reach US$ 22.41 billion by 2033, growing at a compound annual growth rate CAGR of 13.2% during the forecast period 2025-2033. The market is driven by the rising prevalence of chromosomal abnormalities, increasing maternal age, and growing demand for safe, non-invasive screening methods. NIPT
Unlocking the Future of Prenatal Care: Insights into the Australia Non-Invasive …
Australia's NIPT market is growing as more parents choose safe, early screening for chromosomal abnormalities. Driven by rising maternal age, advanced sequencing technology, and increasing awareness, NIPT offers high accuracy without invasive procedures. As labs expand test panels and policymakers consider broader reimbursement, NIPT is reshaping prenatal care, making comprehensive and reliable insights accessible to expecting families across Australia. The Australian non-invasive prenatal testing (NIPT) market is undergoing remarkable growth, transforming
Revolutionizing Prenatal Care: Insights into the Growing Non-Invasive Prenatal T …
Mordor Intelligence has published a new report on the Non-invasive Prenatal Testing Market, offering a comprehensive analysis of trends, growth drivers, and future projections. The global non-invasive prenatal testing (NIPT) market is projected to expand significantly, with expectations to grow from USD 3.90 billion in 2025 to USD 7.35 billion by 2030, reflecting a compound annual growth rate (CAGR) of 13.5%. This growth is primarily attributed to
Prenatal Diagnostics Market Companies Overview 2019 - 2027
Global Prenatal Diagnostics Market: Overview Prenatal diagnostics is a procedure for testing the fetus before birth to determine certain hereditary disorders such as Down's syndrome, genetic diseases, chromosome abnormalities, neural tube defects, and other conditions. In case of high risk related to the birth of a child, it can assist by conducting numerous procedures of genetic testing common testing, and screening. Report Overview @ https://www.transparencymarketresearch.com/prenatal-diagnostics-market.html The global prenatal diagnostics market is segmented on
Non-Invasive Prenatal Testing Market : Lucrative Opportunities
Non-Invasive Prenatal Testing Market: Introduction Transparency Market Research has published a new report titled 'Global Non-Invasive Prenatal Testing Market'. According to the report, the global non-invasive prenatal testing market was valued at approximately US$ 1.3 Bn in 2018. The global non-invasive prenatal testing market is expected to expand at a CAGR of 16.4% during the forecast period from 2019 to 2027. Overview Rise in prevalence of chronic conditions, such as cancer and diabetes,
Prenatal Vitamin Supplements Market: Rising Incidence of Prenatal Defects to Fue …
Global Prenatal Vitamin Supplements Market: Overview Prenatal vitamins are the mineral and vitamin supplements used by during their pregnancy for the healthy development of the fetus. Prenatal vitamins are also recommended by doctors before conception and post conception lactation period. These vitamins are like other common man multivitamins but with different concentration of vitamins and some special vitamins required during pregnancy. Most of these vitamins are prescribed as regulated by U.S.